Form D · Pharmaceuticals

TESARO, Inc.

Waltham, MA · CIK 0001491576

Offering snapshot reported Apr 18, 2016 · SEC filing

Reported sold
$50M
Offering amount: $50M
Investors reported
1
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Apr 5, 2016
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 18, 2016Initial$49,999,960No comparison1SEC filing
Mar 10, 2016Initial$154,999,915No comparison7SEC filing
Jun 21, 2011Initial$40,000,000No comparison17SEC filing
May 20, 2010Initial$10,000,000No comparison5SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-261523

Source: Form D, filed Apr 18, 2016. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Lawrence M. Alleva Director
James O. Armitage Director
Grant C. Bogle Executive
Earl M. Collier, Jr. Director
Joseph L. Farmer Executive
Jeffrey H. Hanke Executive
Mary Lynne Hedley Director, Executive
Mary Lynne Hedley Director, Executive
Martin H. Huber Executive
David M. Mott Director
Leon O. Moulder Jr. Director, Executive
Leon O. Moulder, Jr. Director, Executive
Garry A. Nicholson Director
Arnold L. Oronsky Director
Kavita Patel Director
Timothy R. Pearson Executive
Richard J. Rodgers Executive
Beth Seidenberg Director
Paul Walker Director

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
1000 Winter Street, Suite 3300
Waltham, MA, 02451